The per capita value of the Penicillins and Streptomycins Dosage Market in Spain has shown a consistent decline from 2013 to 2023, decreasing from $6.63 to $3.89. This represents a year-on-year decrease of approximately 4.4% in the last two years, with the compound annual growth rate (CAGR) over the past five years being around -3.9%. This trend suggests a shrinking market for these pharmaceuticals in Spain.
Future trends to watch for:
- Potential stabilization of the market as healthcare developments evolve.
- Changes in regulation or healthcare policy that may impact antibiotic usage.
- Advances in medical research potentially leading to alternative treatments.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 12 | 12 Portugal | 4.91 | 2023 | View data | ||
| 13 | 13 El Salvador | 4.03 | 2023 | View data | ||
| 14 | 14 Spain | 3.89 | 2023 | |||
| 15 | 15 Poland | 3.78 | 2023 | View data | ||
| 16 | 16 Chile | 3.56 | 2023 | View data | ||
